Impact of breast-, gastrointestinal-, and lung cancer on prognosis in patients with first-time pulmonary embolism: A Danish nationwide cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Impact of breast-, gastrointestinal-, and lung cancer on prognosis in patients with first-time pulmonary embolism : A Danish nationwide cohort study. / Nouhravesh, Nina; Strange, Jarl E.; Sindet-Pedersen, Caroline; Holt, Anders; Tønnesen, Jacob; Andersen, Camilla Fuchs; Nielsen, Sebastian K.; Grove, Erik L.; Nielsen, Dorte; Schou, Morten; Lamberts, Morten.

I: International Journal of Cardiology, Bind 406, 132001, 2024.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Nouhravesh, N, Strange, JE, Sindet-Pedersen, C, Holt, A, Tønnesen, J, Andersen, CF, Nielsen, SK, Grove, EL, Nielsen, D, Schou, M & Lamberts, M 2024, 'Impact of breast-, gastrointestinal-, and lung cancer on prognosis in patients with first-time pulmonary embolism: A Danish nationwide cohort study', International Journal of Cardiology, bind 406, 132001. https://doi.org/10.1016/j.ijcard.2024.132001

APA

Nouhravesh, N., Strange, J. E., Sindet-Pedersen, C., Holt, A., Tønnesen, J., Andersen, C. F., Nielsen, S. K., Grove, E. L., Nielsen, D., Schou, M., & Lamberts, M. (2024). Impact of breast-, gastrointestinal-, and lung cancer on prognosis in patients with first-time pulmonary embolism: A Danish nationwide cohort study. International Journal of Cardiology, 406, [132001]. https://doi.org/10.1016/j.ijcard.2024.132001

Vancouver

Nouhravesh N, Strange JE, Sindet-Pedersen C, Holt A, Tønnesen J, Andersen CF o.a. Impact of breast-, gastrointestinal-, and lung cancer on prognosis in patients with first-time pulmonary embolism: A Danish nationwide cohort study. International Journal of Cardiology. 2024;406. 132001. https://doi.org/10.1016/j.ijcard.2024.132001

Author

Nouhravesh, Nina ; Strange, Jarl E. ; Sindet-Pedersen, Caroline ; Holt, Anders ; Tønnesen, Jacob ; Andersen, Camilla Fuchs ; Nielsen, Sebastian K. ; Grove, Erik L. ; Nielsen, Dorte ; Schou, Morten ; Lamberts, Morten. / Impact of breast-, gastrointestinal-, and lung cancer on prognosis in patients with first-time pulmonary embolism : A Danish nationwide cohort study. I: International Journal of Cardiology. 2024 ; Bind 406.

Bibtex

@article{b26551bf74754bce8f4555f4260ef64d,
title = "Impact of breast-, gastrointestinal-, and lung cancer on prognosis in patients with first-time pulmonary embolism: A Danish nationwide cohort study",
abstract = "Background: Pulmonary embolism (PE) is described as a prognostic factor in patients with cancer however, the prognostic impact of PE remains unknown. This study investigated, the 1-year prognosis following PE in patients with breast-, gastrointestinal-, or lung cancer stratified by cancer status. Methods: All Danish patients with first-time PE from 2008 to 2018 were included. Cancer status was categorized as no cancer, history of cancer, non-active cancer and active cancer. Unadjusted and age-stratified 1-year risk of death was estimated using the Kaplan-Meier estimator. Cause of death was reported using the Aalen-Johansen method. Results: Of 35,679 patients with PE, 18% had a breast-, gastrointestinal-, or lung cancer. Patients with cancer were older compared with no cancer (69.8 years [IQR: 56.2–79.8]). One-year risk of death (95% confidence interval) for active breast-, gastrointestinal-, and lung cancer was 49.5% (44.0%–54.9%), 75.0% (72.5%–77.4%) and 80.1% (78.0%–82.3%) respectively, compared with 18.9% (18.4%–19.3%) for no cancer. Age-stratified analysis revealed no association with increasing age in non-active lung cancer and all active cancers. Further, non-cardiovascular death accounted for an increasing proportion by cancer status (no cancer < history of cancer < non-active cancer < active cancer). Conclusions: One-year risk of death was dependent on both cancer type and status; no association with age was found for patients with active cancers. Non-cardiovascular death was leading in non-active and active cancers. Thus, the occurrence of first-time PE could be regarded as a marker of cancer severity for patients with breast-, gastrointestinal-, and lung cancer.",
keywords = "Breast cancer, Cardio-oncology, Gastrointestinal cancer, Lung cancer, Pulmonary embolism",
author = "Nina Nouhravesh and Strange, {Jarl E.} and Caroline Sindet-Pedersen and Anders Holt and Jacob T{\o}nnesen and Andersen, {Camilla Fuchs} and Nielsen, {Sebastian K.} and Grove, {Erik L.} and Dorte Nielsen and Morten Schou and Morten Lamberts",
note = "Publisher Copyright: {\textcopyright} 2024 The Authors",
year = "2024",
doi = "10.1016/j.ijcard.2024.132001",
language = "English",
volume = "406",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",

}

RIS

TY - JOUR

T1 - Impact of breast-, gastrointestinal-, and lung cancer on prognosis in patients with first-time pulmonary embolism

T2 - A Danish nationwide cohort study

AU - Nouhravesh, Nina

AU - Strange, Jarl E.

AU - Sindet-Pedersen, Caroline

AU - Holt, Anders

AU - Tønnesen, Jacob

AU - Andersen, Camilla Fuchs

AU - Nielsen, Sebastian K.

AU - Grove, Erik L.

AU - Nielsen, Dorte

AU - Schou, Morten

AU - Lamberts, Morten

N1 - Publisher Copyright: © 2024 The Authors

PY - 2024

Y1 - 2024

N2 - Background: Pulmonary embolism (PE) is described as a prognostic factor in patients with cancer however, the prognostic impact of PE remains unknown. This study investigated, the 1-year prognosis following PE in patients with breast-, gastrointestinal-, or lung cancer stratified by cancer status. Methods: All Danish patients with first-time PE from 2008 to 2018 were included. Cancer status was categorized as no cancer, history of cancer, non-active cancer and active cancer. Unadjusted and age-stratified 1-year risk of death was estimated using the Kaplan-Meier estimator. Cause of death was reported using the Aalen-Johansen method. Results: Of 35,679 patients with PE, 18% had a breast-, gastrointestinal-, or lung cancer. Patients with cancer were older compared with no cancer (69.8 years [IQR: 56.2–79.8]). One-year risk of death (95% confidence interval) for active breast-, gastrointestinal-, and lung cancer was 49.5% (44.0%–54.9%), 75.0% (72.5%–77.4%) and 80.1% (78.0%–82.3%) respectively, compared with 18.9% (18.4%–19.3%) for no cancer. Age-stratified analysis revealed no association with increasing age in non-active lung cancer and all active cancers. Further, non-cardiovascular death accounted for an increasing proportion by cancer status (no cancer < history of cancer < non-active cancer < active cancer). Conclusions: One-year risk of death was dependent on both cancer type and status; no association with age was found for patients with active cancers. Non-cardiovascular death was leading in non-active and active cancers. Thus, the occurrence of first-time PE could be regarded as a marker of cancer severity for patients with breast-, gastrointestinal-, and lung cancer.

AB - Background: Pulmonary embolism (PE) is described as a prognostic factor in patients with cancer however, the prognostic impact of PE remains unknown. This study investigated, the 1-year prognosis following PE in patients with breast-, gastrointestinal-, or lung cancer stratified by cancer status. Methods: All Danish patients with first-time PE from 2008 to 2018 were included. Cancer status was categorized as no cancer, history of cancer, non-active cancer and active cancer. Unadjusted and age-stratified 1-year risk of death was estimated using the Kaplan-Meier estimator. Cause of death was reported using the Aalen-Johansen method. Results: Of 35,679 patients with PE, 18% had a breast-, gastrointestinal-, or lung cancer. Patients with cancer were older compared with no cancer (69.8 years [IQR: 56.2–79.8]). One-year risk of death (95% confidence interval) for active breast-, gastrointestinal-, and lung cancer was 49.5% (44.0%–54.9%), 75.0% (72.5%–77.4%) and 80.1% (78.0%–82.3%) respectively, compared with 18.9% (18.4%–19.3%) for no cancer. Age-stratified analysis revealed no association with increasing age in non-active lung cancer and all active cancers. Further, non-cardiovascular death accounted for an increasing proportion by cancer status (no cancer < history of cancer < non-active cancer < active cancer). Conclusions: One-year risk of death was dependent on both cancer type and status; no association with age was found for patients with active cancers. Non-cardiovascular death was leading in non-active and active cancers. Thus, the occurrence of first-time PE could be regarded as a marker of cancer severity for patients with breast-, gastrointestinal-, and lung cancer.

KW - Breast cancer

KW - Cardio-oncology

KW - Gastrointestinal cancer

KW - Lung cancer

KW - Pulmonary embolism

U2 - 10.1016/j.ijcard.2024.132001

DO - 10.1016/j.ijcard.2024.132001

M3 - Journal article

C2 - 38561107

AN - SCOPUS:85189666922

VL - 406

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

M1 - 132001

ER -

ID: 391620564